The Senior Director, Business Development Transactionssupportsthe execution of complex partnering, licensing, collaboration and acquisition deals that shape CSL’s future portfolio and scientific leadership. This role translatesTAinsights, enterprise strategy and cross-functional perspectives into high-quality transaction structures and negotiation outcomes. It serves as a senior deal strategist, ensuring CSL secures partnerships that deliver scientific, commercial, and financial value while managing enterprise risk with discipline.
RESPONSIBILITIES AND ACCOUNTABILITIES
List the essential job duties and responsibilities in order of priority or time spent on each. Include only those items that are the sole or primary reason the job exists, items that require specialized skills or training, and items that demanda significant portionof time to perform (Do not list competencies, education, training requirements, etc.).
Transaction Execution Leadership
Leadexecution of CSL’s high-priority licensing agreements, research collaborations, asset acquisitions, equity-linkeddealsand divestitures
Deal Structuring & Negotiation Strategy
Partner closely withBD TA,Legal/IPandFinance to define defensible positions, valuation baselines, negotiationboundariesand fallback strategies
Lead cross-functional diligence programs covering scientific, clinical, regulatory, commercial, CMC, supply, legal and operational domains
Governance & Decision Support
Enterprise Orchestration & Cross-Functional Partnership
Align stakeholders across R&D, Commercial, Technical Operations,CorporateStrategy, Finance and Enterprise Alliance Management.
Post-Signature Handover & Early-Life Support
Team Leadership & Capability Building
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
